Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 113
Selected: 0
NCT IDTitle
NCT00515957Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)
NCT02291848Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
NCT00085930Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
NCT00082225LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
NCT00040482High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
NCT01853631Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
NCT00058773Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
NCT00881920Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
NCT02379520HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
NCT01604031Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
NCT02276820Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
NCT00078520Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
NCT00586274Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT
NCT00368082Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)
NCT00953420Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
NCT00056966Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
NCT03762291Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
NCT03192462TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
NCT02065362TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
NCT00586391CD19 Chimeric Receptor Expressing T Lymphocytes in B-Cell Non Hodgkin's Lymphoma, ALL & CLL
NCT04715191Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
NCT01555892Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
NCT00880789Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus
NCT00058591Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
NCT00048386Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
NCT03596086HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
NCT01189786Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
NCT00703222A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells
NCT00578539T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
NCT02108522Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
NCT00058786Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells
NCT06198296Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
NCT03093350TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
NCT00368355T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
NCT00539695Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
NCT01109095CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM
NCT00062855Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma
NCT01192555Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
NCT04345601Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
NCT05236764Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
NCT06251544TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
NCT00590460Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia
NCT00040469Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
NCT00950846Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
NCT00710892CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
NCT00069992Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
NCT01192464EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
NCT00458679Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
NCT00578903Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
NCT00078546EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)